ReNAgade Therapeutics
在场
高管
查看带有其 7 名主要高管的组织结构图
ReNAgade Therapeutics 搜索最多的简介
- Brian Shuster, Chief Business Officer
- Joe Bolen, Chief Science Innovation Officer
- Ciaran Lawlor, Chief Strategy Officer
高管在ReNAgade Therapeutics变化
- Joe Bolen已作为Chief Science Innovation Officer加入公司 (新闻发布的2024二月28号).
创建提醒
跟踪 ReNAgade Therapeutics 的高管变动
健康
ReNAgade Therapeutics 拥有 1,966 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
ReNAgade Therapeutics 的最新新闻稿
- News & Media - Orna Therapeutics
- News
- ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
- ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
- ReNAgade Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference
- ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer
- Evercore ISI 2024 Emerging Biotech Conference Webcast
- ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference
- ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors
- ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference
- View more press releases Close
通过电子邮件
